K
Kathryn Anastos
Researcher at Albert Einstein College of Medicine
Publications - 394
Citations - 15007
Kathryn Anastos is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 59, co-authored 351 publications receiving 13391 citations. Previous affiliations of Kathryn Anastos include Lincoln Hospital & Capital Medical University.
Papers
More filters
Journal ArticleDOI
How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
Jonathan Ross,Charles Ingabire,Francine Umwiza,Josephine Gasana,Athanase Munyaneza,Gad Murenzi,Sabin Nsanzimana,Eric Remera,Matthew J. Akiyama,Kathryn Anastos,Adebola Adedimeji +10 more
TL;DR: It is suggested that optimizing early engagement in HIV care under Treat All requires early and ongoing intervention to reduce trauma and stigma, and promote both individual and community benefits of ART.
Journal ArticleDOI
Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study.
Claudio Bravo,Simin Hua,Amy Deik,Jason Lazar,David B. Hanna,Justin M. Scott,Jin Choul Chai,Robert C. Kaplan,Robert C. Kaplan,Kathryn Anastos,Octavio A. Robles,Clary B. Clish,Jorge R. Kizer,Qibin Qi +13 more
TL;DR: Improved understanding of metabolic perturbations and their potential modification could offer new approaches to prevent cardiac dysfunction in this high‐risk group of women with or at risk of HIV with LVDD.
Journal ArticleDOI
Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
Carlos M. Vaamonde,Donald R. Hoover,Kathryn Anastos,Tianren Tan,Qiuhu Shi,Wei Gao,Andrea Kovacs,Mardge H. Cohen,Jack DeHovitz,Marshall J. Glesby +9 more
TL;DR: Higher baseline CD4 count and lower HIV RNA level were associated with poor immunologic response to HAART in women with virologic suppression for at least 6 months, and Persistent low level viremia may also contribute.
Journal ArticleDOI
Serum albumin and kidney function decline in HIV-infected women.
Joshua Lang,Rebecca Scherzer,Phyllis C. Tien,Chirag R. Parikh,Kathryn Anastos,Michelle M. Estrella,Alison G. Abraham,Anjali Sharma,Mardge H. Cohen,Anthony W. Butch,Marek Nowicki,Carl Grunfeld,Carl Grunfeld,Michael G. Shlipak,Michael G. Shlipak +14 more
TL;DR: Lower serum albumin levels were associated strongly with kidney function decline and incident reduced eGFRs in HIV-infected women independent of HIV disease status, body mass index, and albuminuria.
Journal ArticleDOI
Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study.
Christina M. Parrinello,Alan L. Landay,Howard N. Hodis,Stephen J. Gange,Philip J. Norris,Mary Young,Kathryn Anastos,Phyllis C. Tien,Phyllis C. Tien,Xiaonan Xue,Jason Lazar,Lorie Benning,Russell P. Tracy,Robert C. Kaplan +13 more
TL;DR: It remains unknown whether short-term treatment-related changes in standard risk factors may appreciably change risk of cardiovascular disease (CVD) in HIV-infected women.